Introduction
============

Mammalian spermatogenesis is a complex and highly ordered process, in which a diploid progenitor germ cell transforms to highly specialised spermatozoa. This process involves successive mitotic, meiotic and post-meiotic phases. Once meiosis is completed, haploid germ cells termed 'round spermatids' are produced; these spermatids subsequently undergo a series of differentiation steps collectively known as 'spermiogenesis'. In spermiogenesis, round spermatids develop a distinct head, midpiece and tail region; round spermatids also undergo chromatin remodelling, develop an acrosome and become almost completely devoid of cytoplasm. These changes lead to the formation of slender, elongated, mature spermatids, which are released into the lumen of the seminiferous tubule during spermiation ([@b1-mmr-10-04-2009]).

Round haploid spermatids initiate spermiogenesis; successful spermiogenesis is necessary for fertilization, and alterations of this process constitute an important cause of male infertility. This process requires a precise and well coordinated system that regulates the constantly changing patterns of gene and protein expression ([@b2-mmr-10-04-2009]). Therefore, the identification of proteins present in the spermatids can not only provide insights into the molecular basis of spemiogenesis, but also facilitate the identification of cell-specific targets for the diagnosis or induction of male infertility.

Numerous genes involved in spermatogenesis have been identified by differential display ([@b3-mmr-10-04-2009]), serial analysis of gene expression (SAGE) ([@b4-mmr-10-04-2009]) and microarray methods ([@b5-mmr-10-04-2009]). Nevertheless, these methods do not provide pivotal information on the post-transcriptional control of gene expression, changes in protein expression levels and/or protein modifications. In this context, proteomics research has emerged and enhanced our knowledge on cell behavior at the system level, by revealing global patterns of protein content, modification and activity during development ([@b6-mmr-10-04-2009]). Experiments have also been conducted to initiate differential protein expression profiling studies and/or systematic analyses of testicular proteomes in entire organs or isolated spermatogenic cells from various species. Several groups have focused on sperm proteomes, and identified numerous proteins that characterise sperm cells in different mammals ([@b7-mmr-10-04-2009]--[@b11-mmr-10-04-2009]). Although proteomic analyses of the sperm and of different developmental stages of the testis have been performed in different mammalian species, the protein expression profiles of spermiogenesis, particularly of round spermatids, remain unclear.

Mass spectrometry (MS)-based proteomics technology is a powerful tool for large-scale protein identification and quantification ([@b12-mmr-10-04-2009]). Previous proteomic studies have used techniques such as two-dimensional (2-D) polyacrylamide gel electrophoresis (PAGE) and 1-D PAGE of the extracted protein mixture prior to liquid chromatography (LC)-MS/MS identification. Although these techniques require the reduction of sample complexity prior to LC-MS/MS analysis, proteins present in small amounts may not be detectable on the gel, thereby limiting the capacity of MS to identify a number of protein components. A number of quantitative proteomic methods have been developed, including stable isotope labeling and label-free methods ([@b11-mmr-10-04-2009]). The latter is applicable in complex biological systems; in addition, this technique has a number of advantages, such as faster, cleaner and simpler results ([@b13-mmr-10-04-2009],[@b14-mmr-10-04-2009]). Numerous researchers have employed label-free shotgun proteomic techniques ([@b15-mmr-10-04-2009]--[@b17-mmr-10-04-2009]).

Animal models are commonly used to study the molecular regulation of spermatogenesis. Numerous murine models have been established and applied to study the genes that are up- or downregulated in spermatogenesis. Biologically, meiosis and spermiogenesis are quite similar processes between humans and rodents. In the current study, label-free quantitative shotgun proteomics and mass spectrometry were combined to investigate the protein content of the round spermatids of mice, in order to provide new insights into the molecular regulation of spermiogenesis.

Materials and methods
=====================

Sample preparation
------------------

Round spermatids were isolated according to a previously described method ([@b18-mmr-10-04-2009]) with slight modifications. In the first wave of mouse spermatogenesis, different spermatogenic cells were found at specific time points (days 6, 9, 14, 21, 35 and 60 postpartum). Based on the majority of germ cell types, male mice of different ages are commonly used to isolate differently developed stages of spermatogenic cell types. In this study, ten 35-day old male Balb/c mice were used to isolate round spermatids. The mice were anesthetized with CO~2~ and sacrificed by cervical dislocation. The testes were then removed and decapsulated. The tubulous tissue was cut into small pieces and incubated in 5 ml of phosphate-buffered saline (PBS) containing 0.5 mg/ml of collagenase (Sigma-Aldrich, St. Louis, MO, USA) with continuous agitation at 33°C for 15 min. The dispersed seminiferous cords and cells were allowed to sediment for 5 min and the supernatant was decanted. The pellet was resuspended in 5 ml of PBS containing 0.5 mg/ml of trypsin (Sigma-Aldrich) and 1 μg/ml of DNase (Promega, Madison, WI, USA), and incubated under the same conditions for 15 min. The tissue was dissociated to disperse seminiferous cells by gently pipetting with a Pasteur pipette; the cell suspension was then centrifuged at 80 × g for 10 min. The pellet was washed twice with PBS, filtered using a filter cloth (200 mesh) and resuspended in 20 ml of PBS solution containing 0.5% bovine serum albumin (BSA).

A total of 10^8^ cells were bottom-loaded in a cell separator apparatus with a 12.5 cm diameter (TH-300A; Shanghai Huxi Analysis Instrument Factory Co., Ltd., Shanghai, China) and then incubated in a 2--4% BSA linear gradient in RPMI-1640 medium (Gibco, Grand Island, NY, USA). After 3 h of velocity sedimentation at unit gravity, the cell fractions (10 ml/fraction) were collected from the bottom of the separator apparatus at a rate of 5 ml/min. The cell types, in terms of diameter and morphological characteristics, as well as the purity of each fraction, were assessed under a light microscope (BX43; Olympus Co., Tokyo, Japan). Only fractions with the expected cell type were pooled together. The average purity of round spermatids was 95%.

Protein extraction
------------------

Cells were washed twice with PBS and then lysed by sonication on ice in a buffer containing 7 M urea, 2 M thiourea, 4% CHAPS, 65 mM DTT and 0.2% Biolyte (Bio-Rad, Richmond, CA, USA). Following sonication, the lysates were centrifuged (10,000 × g, 1 h at 4°C), and the supernatants were collected. The protein concentration of each supernatant was assayed using a standard Bradford protein assay kit (Bio-Rad). Approximately 100 μg of the protein sample was reduced using 10 mM DTT at 37°C for 2.5 h, and alkylated with 50 mM iodoacetamide (both from Sigma-Aldrich) at room temperature for 40 min. The sample was then diluted in a solution of 50 mM NH~4~HCO~3~ (Sigma-Aldrich). The protein mixture was digested by incubating in grade-modified trypsin (Promega) at a 1:50 enzyme:protein ratio, at 37°C for 20 h. The tryptic peptide mixture was lyophilized and stored at −80°C until use.

Immunofluorescent detection
---------------------------

Cells were attached to poly-L-lysine coated microscopy coverslips and were fixed with 2% formaldehyde in microtubule-stabilizing buffer (50 mmol/l PIPES, 5 mmol/l EGTA and 5 mmol/l MgSO~4~) for 1 h. Coverslips were rinsed in PBS and permeabilized for 1 h in 1% Triton X-100 in PBS. Nonspecific antibody binding was prevented by incubation for 1 h in 10% normal goat serum. Microtubules were labeled with anti-α-tubulin monoclonal (Sigma-Aldrich). Primary antibodies were detected using FITC-conjugated rabbit anti-mouse immunoglobulin (Jackson ImmunoResearch Inc., West Grove, PA, USA). DNA was detected by labeling with DAPI. The coverslips were mounted in a drop of VectaShield mounting medium (Vector Laboratories Inc, Burlingame, CA, USA). Coverslips were examined using BX43 Epifluorescence microscope (Olympus Co.).

Automated 2D-nano-LC-ESI-MS/MS peptide analysis
-----------------------------------------------

The extracted peptides were desalted using 1.3 ml C18 solid-phase extraction column (Sep-Pak^®^ Cartridge; Waters Corp., Milford, MA, USA). The peptides were dried using a vacuum centrifuge and were resuspended in loading buffer containing 5 mM ammonium formate (NH~4~FA) and 5% acetonitrile at pH 3.0, Next, peptides were separated and analyzed by 2D strong cation-exchange (SCX)/reversed-phase (RP) nano-scale LC/MS. The experiments were performed on a Nano Aquity UPLC system (Waters Corp.) connected to an LTQ Orbitrap XL mass spectrometer (Thermo Electron Corp., Bremen, Germany) equipped with an online nano-electrospray ion source (Bruker, Auburn, CA, USA).

A 180 μm × 2.4 cm SCX column (Waters Corp), which was packed with 5 μm of polysulfoethyl aspartamide (PolyLC Inc., Columbia, MD, USA) was used for the first dimension. To recover hydrophobic peptides retained on the SCX column after a conventional salt step gradient, an RP step gradient from 5 to 50% acetonitrile (ACN) was applied to the SCX column. A 15-μl plug was performed at each step of the gradient. The SCX column was cleaned once using 1 M NH~4~FA. The plugs were then loaded onto the SCX column with loading buffer, at a flow rate of 15 μl/min for 6 min. A peptide sample (15 μl) was loaded onto the SCX column prior to injection of the gradient plugs. The eluted peptides were then captured using a trap column (Waters Corp.), and salts were diverted to waste. The trap column (2 cm × 180 μm) was packed with a 5 μm Symmetry^®^ C18 column (Waters Corp.). The RP analytical column (15 cm × 100 μm) was packed with a 1.7 μm bridged ethyl hybrid (BEH) C18 particle (Waters Corp.) and then used for protein separation at the second dimension.

The peptides on the RP analytical column were eluted with a three-step linear gradient, balancing with the 95% A buffer 10 min, then starting from 5 to 40% B in 40 min (A, water with 0.1% formic acid; B, ACN with 0.1% formic acid) and increased up to 80% B in 3 min. Afterwards, this solution was reduced to 5% B for 2 min. The column was left to re-equilibrate for 15 min. The column flow rate was maintained at 500 nl/min and the column temperature was maintained at 35°C. Eluted peptides were ionized at 1.9 kV and the ions were analyzed by an LTQ Orbitrap XL Mass spectrometer (Thermo Fisher Scientific Inc., Marietta, OH, USA).

The LTQ Orbitrap XL mass spectrometer was operated in a data-dependent mode to switch automatically between MS and MS/MS acquisition. Survey full-scan MS spectra with two microscans (300--1800 m/z) were acquired in the Obitrap with a mass resolution of 60,000 at 400 m/z. Ten sequential LTQ-MS/MS scans were then conducted. Dynamic exclusion was used with two repeat counts, 10 sec repeat duration and 90 sec exclusion duration. For MS/MS, precursor ions were activated using a 35% normalized collision energy at the default activation q-value of 0.25.

Peptide sequencing data analysis
--------------------------------

The acquired MS/MS spectra were searched against the IPI mouse.v3.68 fasta-formatted protein database using the SEQUEST v.28 (revision 12) software (Thermo Electron Corp.). To reduce identification of false positives, we appended to the database its decoy version containing the reverse sequences. The search parameters were the following: partial trypsin (KR) cleavage with two missed cleavages; the variable modification was oxidation (M); peptide mass tolerance, 50 ppm; and fragment ion tolerance, 1 Da. The open-source Trans Proteomic Pipeline software (revision 4.0; Institute of Systems Biology, Seattle, WA, USA) was then used to identify proteins based on the corresponding peptide sequences and a ≥95% confidence threshold. The peptides results were filtered by Peptide Prophet ([@b19-mmr-10-04-2009]) with a p-value \>0.95 and a Protein Prophet ([@b20-mmr-10-04-2009]) probability of 0.95 was used for the protein identification results.

Bioinformatic analyses
----------------------

The predicted cellular localization of the proteins identified in the round spermatids was retrieved based on the information available at the Gene Ontology (GO)project website (<http://www.geneontology.org/>). Functional classification of the proteins was based on biological process and molecular function GO terms. Assignment of the proteins to signaling pathways was based on information available at the Kyoto Encyclopedia of Genes and Genomes (KEGG) (<http://www.genome.jp/kegg/pathway.html>) and the BioCarta (<http://www.biocarta.com/genes/index.asp>) databases. Enrichment analysis for these categorizations was performed with tools available at DAVID Bioinformatics Resources (<http://david.abcc.ncifcrf.gov/>); DAVID is a web-based application that enables visualization, discovery and analysis of molecular interactions and associations with disease for a given list of genes or proteins.

Results
=======

Identification of proteins in round spermatids by shotgun proteomics
--------------------------------------------------------------------

Following isolation of murine testicular cells by a gradient method, the purity of the sorted round spermatids was assessed by immunofluorescent staining using the anti-α-tubulin antibody. α-tubulin is the main component of manchette, which is a spermatid-specific microtubular structure. The purity of the sorted round spermatids was \>95%, as assessed by counting 500 sorted cells under the microscope ([Fig. 1](#f1-mmr-10-04-2009){ref-type="fig"}).

We employed a label-free shotgun proteomic technique to identify proteins, gain insights into the protein expression profile of round spermatids, and investigate the relevant molecular mechanisms. The reproducibility of the method was evaluated, with a reliability coefficient of 95% estimated from independent experiments. We found that the peptide spectral intensity is higher than the spectral counts in the quantification of proteomic analysis. The average peptide spectral intensity was used as a standard for the relative quantification of proteins. A total of 2,331 proteins were identified by using the sequenced peptides as queries in searches against the IPI mouse database. Repeating the search against the related decoy database with the same parameters yielded a low (1%) false discovery rate (FDR) at the peptide level, indicating that our approach has high specificity.

Enriched pathways and functional categories
-------------------------------------------

Among the 2,331 identified proteins, 2,287 were found to correspond to unique genes. To characterize these proteins, we initially categorized them based on biological process terms of GO and conducted an enrichment analysis. The most significant categories are shown in [Table I](#tI-mmr-10-04-2009){ref-type="table"}. These processes include the generation of precursor metabolites and energy (504), translation and protein targeting (343), nucleotide and nucleic acid metabolism (298), transport (275) and cellular component organization (289). Some of the identified proteins were associated with cytoskeleton organization (183), protein degradation (116) or response to stimulus (115). Approximately 164 proteins with unknown functions were also identified in the proteome of round spermatids. The full classification of the unknown-function proteins with regards to the biological processes they are associated with is demonstrated in a pie chart in [Fig. 2](#f2-mmr-10-04-2009){ref-type="fig"}.

Furthermore, the predicted molecular function and subcellular localization of the identified proteins was retrieved from GO and enrichment analysis was performed with DAVID tools. A total of 1,818 identified proteins were classified into 9 groups according to their molecular function: binding (866); catalytic activity (400); structural molecule activity (155); motor activity (150); translation regulator activity ([@b35-mmr-10-04-2009]); anti-oxidant activity ([@b19-mmr-10-04-2009]); and enzyme inhibitor activity (43). The full classification of 1,818 proteins is shown in a pie chart in [Fig. 3](#f3-mmr-10-04-2009){ref-type="fig"}.

[Fig. 4](#f4-mmr-10-04-2009){ref-type="fig"} shows the classification of the proteins identified in this study according to their predicted subcellular localization. If an individual protein was predicted to localize in more than one cellular compartment, all localizations were counted non-exclusively. The largest proportion of the identified proteins was associated with the mitochondrion (486), followed by the following cell parts/organelles: cytoplasm (327); cytoskeleton (227); endoplasmic reticulum (260); nucleus (194); Golgi apparatus (151); membrane (148); and lysosome (45).

To investigate the pathways governing the behavior of round spermatids, we further classified the proteins based on KEGG pathway terms. As expected, an important proportion of the identified proteins (370) were involved in metabolic pathways. Among these proteins, 81 were involved in the oxidative phosphorylation pathway ([Fig. 5A](#f5-mmr-10-04-2009){ref-type="fig"}) that supports spermatid maturation, and 34 were related to the fatty acid metabolism pathway. This pathway provides the necessary energy for spermatid maturation. In addition, 27 proteins were bound to the citric acid (TCA) cycle ([Fig. 5B](#f5-mmr-10-04-2009){ref-type="fig"}) and 92 proteins were involved in sugar metabolism pathways, such as glycolysis, gluconeogenesis, pyruvate metabolism, starch and sucrose metabolism and the pentose phosphate pathway (data not shown).

In addition to the proteins involved in metabolism, a large group of proteins essential for translation were identified in round spermatids. A total of 68 proteins were annotated as parts of the ribosomal pathway, and 17 proteins as related to aminoacyl-tRNA biosynthesis. Numerous proteins were also involved in protein degradation. We found that the round spermatid proteome contained 28 proteins in the proteasome pathway and 40 proteins in the lysosome pathway ([Fig. 6A and B](#f6-mmr-10-04-2009){ref-type="fig"}). Pathway annotation of the haploid proteome by the Pathway Studio software (<http://www.elsevier.com/online-tools/pathway-studio/pathway-studio-web>) revealed that 60 proteins are components of the spliceosome pathway, in which heterogeneous nuclear RNA (hnRNA) is converted to mRNA ([Fig. 7](#f7-mmr-10-04-2009){ref-type="fig"}).

Numerous actin and actin-binding proteins participate in the formation of sperm. LC-MS/MS analysis performed in this study identified \~94 actin-binding proteins, involved in the regulation of the actin cytoskeleton KEGG pathway in round spermatids of mice ([Fig. 8A and B](#f8-mmr-10-04-2009){ref-type="fig"}).

A total of 25 proteins involved in gap junctions, 44 proteins in tight junctions and 26 proteins in adherens junctions were also detected. Seven proteins involved in the nucleocytoplasmic transport pathway ([Fig. 9](#f9-mmr-10-04-2009){ref-type="fig"}) and nine proteins related to the caspase cascade of the apoptotic signaling pathway were also identified. Full results from the pathway analysis are shown in [Table II](#tII-mmr-10-04-2009){ref-type="table"}.

Discussion
==========

The proteome of a cell or an organelle provides information regarding the ensemble of proteins expressed in that particular cell or organelle, and the modification of proteins under specific physiological conditions and time points ([@b21-mmr-10-04-2009]). Label-free proteomics is a rapidly growing MS-based quantitative proteomic workflow, since it does not require chemical labeling; quantification is thus unaffected by labelling efficiencies ([@b22-mmr-10-04-2009]). In order to fully characterise spermiogenesis, and in particular the biological characteristics of round spermatids, we obtained, using a label-free proteomic approach, the full proteome of 2,331 proteins of round spermatids of mice; among these proteins, 2,287 mapped to unique genes.

Spermatogenesis is a complex and highly ordered process, which begins with the differentiation of spermatogonial stem cells and ends with the formation of mature sperm. In haploid germ cell differentiation (or spermiogenesis), round spermatids undergo marked morphological changes. The nucleus becomes more compact, the mitochondria are rearranged, the flagellum develops and an acrosome is formed ([@b23-mmr-10-04-2009]). In the present study, β-1-globin, β-2-globin and histone H4 were found to be expressed in round spermatids (data not shown). These proteins are constituents of the chromatin structure and participate in gene regulation ([@b24-mmr-10-04-2009]).

Energy metabolism is a key process for the development of round spermatids. Round spermatids require ATP, most probably to sustain morphological changes, as well as active protein degradation and synthesis. In round spermatids, lactate and pyruvate are the preferred substrates for the generation of energy; the use of glucose is limited ([@b25-mmr-10-04-2009]). In our study, 504 proteins were identified as involved in the generation of precursor metabolites and energy ([Table I](#tI-mmr-10-04-2009){ref-type="table"}). The TCA cycle is the main energy resource of round spermatids, although glycolytic and pentose phosphate pathways also contribute to energy production in the spermatids ([@b26-mmr-10-04-2009]). Citrate synthase, isocitrate dehydrogenase and α-oxoglutarate dehydrogenase are expressed in round spermatids ([Table I](#tI-mmr-10-04-2009){ref-type="table"} and [Fig. 5B](#f5-mmr-10-04-2009){ref-type="fig"}). L-lactate dehydrogenase, pyruvate kinase and pyruvate dehydrogenase, which are involved in the glycolytic pathway, are also expressed in round spermatids. Pyruvate kinase is fully activated in round spermatids when glucose is metabolized by the glycolytic pathway ([@b27-mmr-10-04-2009]). A total of 81 proteins were identified as involved in the oxidative phosphorylation pathway in round spermatids ([Fig. 5A](#f5-mmr-10-04-2009){ref-type="fig"}); these proteins may be involved in the formation and in reactions occurring in the acrosome, which require energy provided by oxidative phosphorylation ([@b25-mmr-10-04-2009]).

At the stage of development of round spermatids, numerous proteins and organelles are degraded; the ubiquitin-proteasome and the lysosome pathways are important, particularly in facilitating the formation of condensed sperms. In the present study, 28 proteins were found as involved in the proteasome pathway and 40 proteins in the lysosome pathway ([Fig. 6A and B](#f6-mmr-10-04-2009){ref-type="fig"}). Post-translational protein modification by ubiquitination is a signal for lysosomal or proteasomal proteolysis. UBA6 is an E1-activating enzyme, which can activate ubiquitin and FAT10 ([@b28-mmr-10-04-2009],[@b29-mmr-10-04-2009]). UBA6 uses a specific E2 enzyme, namely, Use1, which cooperates with E3 enzymes to ubiquitylate a unique subset of protein substrates ([@b30-mmr-10-04-2009]). CUL4 is an E3 ubiquitin ligase; in the absence of a functional *CUL4* gene, a decreased number of spermatozoa, reduced sperm motility and defective acrosome formation are observed ([@b31-mmr-10-04-2009]). The ubiquitination of proteins can be regulated and reversed by deubiquitinating enzymes. Ubiquitin C-terminal hydrolases (UCHs) are responsible for the removal of polyubiquitin chains during substrate priming for proteasomal proteolysis. UCHL1 and UCHL3, which were identified in round spermatids in our study, are involved in sperm acrosomal formation and function; these enzymes are known to be important for fertilization ([@b32-mmr-10-04-2009],[@b33-mmr-10-04-2009]).

Transcription during spermatogenesis begins in almost-round spermatids; these transcripts are then translated during spermatid elongation and acrosome formation ([@b34-mmr-10-04-2009],[@b35-mmr-10-04-2009]). In our study, 60 proteins were annotated as parts of the spliceosome pathway, in which hnRNA is converted to mRNA and translated to proteins ([Fig. 7](#f7-mmr-10-04-2009){ref-type="fig"}). Following protein synthesis, some proteins are translocated between the nuclear and cytoplasmic compartments to allow the essential cellular responses to extracellular and intracellular signals. In our study, seven proteins, such as SRP19 and SRP72, were identified as involved in protein transport and regulation of signal transduction ([@b36-mmr-10-04-2009],[@b37-mmr-10-04-2009]).

Acrosome formation and spermatid nuclear shaping are two major processes of spermiogenesis. Actin and actin-binding proteins are implicated in various aspects, including acrosome formation and nuclear shaping of the spermatids during spermiogenesis. Actin is also involved in germ cell movement, protein transport and nuclear modifications. Numerous actin-binding proteins are found in actin-rich sites, and these proteins bind to actin filaments and modulate their corresponding properties and functions. Myosin, an actin-dependent molecular motor, is involved in a number of important functions in spermiogenesis, such as acrosome biogenesis, vesicle transport, gene transcription and nuclear shaping ([@b38-mmr-10-04-2009],[@b39-mmr-10-04-2009]). In the current study, \~94 proteins were predicted to be involved in the regulation of the actin cytoskeleton in the round spermatids of mice ([Fig. 8](#f8-mmr-10-04-2009){ref-type="fig"}).

Numerous studies have focused on the proteomic analysis of spermatogenesis. Nevertheless, current knowledge on the proteome of round spermatids is limited, and the detailed protein patterns of round spermatids remain unknown. Thus, large-scale proteomic approaches such as the one employed in the present study, can provide a rich resource in the study of spermiogenesis, and enrich our knowledge on the biological functions of round spermatids.

In conclusion, this study is the first, to the best of our knowledge, to conduct a proteomic analysis of round spermatids. Round spermatids are formed in a specific phase of spermatogenesis. We performed label-free quantification analysis and identified 2,287 unique proteins, which are involved in energy metabolism, transcription, protein synthesis and degradation, and nucleocytoplasmic transport. These biological processes facilitate the morphological changes to which round spermatids are subjected. The proteome analysis performed in the current study provided a comprehensive characterization of the protein expression profiles of round spermatids. Therefore, the present study is expected to enhance our understanding of the molecular basis of spermatogenesis.

This study was supported by the Scientific Research Foundation for Returned Scholars of Shanxi Province (2011-043, 2010-677).

![Immunofluorescent staining of purified mouse round spermatids with (A) DAPI (blue), (B) anti-α-tubulin (green), and (C) DAPI and anti-α-tubulin. Strong anti-α-tubulin staining was observed in almost all cells. Scale bar, 20 μm.](MMR-10-04-2009-g00){#f1-mmr-10-04-2009}
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![Pathway analysis using the Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway database. Proteins involved in the (A) oxidative phosphorylation pathway (n=81) and (B) the citrate (TCA) cycle (n=27). Red stars denote the detected proteins.](MMR-10-04-2009-g04){#f5-mmr-10-04-2009}

![Pathway analysis using the Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway database. Proteins involved in the (A) proteasome pathway (n=28) and (B) the lysosome pathway (n=40). Stars denote the detected proteins.](MMR-10-04-2009-g05){#f6-mmr-10-04-2009}

![Pathway analysis using the Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway database. Proteins involved in the spliceosome pathway (n=60) are shown. Stars denote the detected proteins.](MMR-10-04-2009-g06){#f7-mmr-10-04-2009}

![Pathway analysis using the Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway database. Proteins involved in regulation of the actin cytoskeleton (actin-binding) are shown (n=94).](MMR-10-04-2009-g07){#f8-mmr-10-04-2009}

![Pathway analysis using the Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway database. Proteins participating in the nucleocytoplasmic transport pathway (n=7) are shown. Red stars denote the detected proteins.](MMR-10-04-2009-g08){#f9-mmr-10-04-2009}

###### 

Enriched biological processes in the proteome of round spermatids based on Gene Ontology (GO) terms.

  GO id.       Description                                                                Count   \%              Q\<0.01
  ------------ -------------------------------------------------------------------------- ------- --------------- -----------
  GO:0055114   Oxidation reduction                                                        234     10.3356890460   4.40E-58
  GO:0008104   Protein localization                                                       198     8.7455830389    1.24E-50
  GO:0045184   Establishment of protein localization                                      180     7.9505300353    4.11E-33
  GO:0015031   Protein transport                                                          179     7.9063604240    9.98E-31
  GO:0006091   Generation of precursor metabolites and energy                             142     6.2720848057    2.54E-24
  GO:0046907   Intracellular transport                                                    135     5.9628975265    2.68E-24
  GO:0006412   Translation                                                                126     5.5653710247    2.77E-24
  GO:0042592   Homeostatic process                                                        114     5.0353356890    5.88E-24
  GO:0016192   Vesicle-mediated transport                                                 105     4.6378091873    1.32E-23
  GO:0007155   Cell adhesion                                                              100     4.4169611307    1.30E-21
  GO:0022610   Biological adhesion                                                        100     4.4169611307    2.13E-21
  GO:0034613   Cellular protein localization                                              97      4.2844522968    7.58E-20
  GO:0070727   Cellular macromolecule localization                                        97      4.2844522968    5.06E-19
  GO:0006886   Intracellular protein transport                                            93      4.1077738516    1.53E-18
  GO:0006396   RNA processing                                                             90      3.9752650177    2.20E-18
  GO:0044271   Nitrogen compound biosynthetic process                                     88      3.8869257951    2.54E-18
  GO:0016071   mRNA metabolic process                                                     84      3.7102473498    5.99E-18
  GO:0055085   Transmembrane transport                                                    83      3.6660777385    1.56E-17
  GO:0019725   Cellular homeostasis                                                       81      3.5777385159    5.15E-17
  GO:0043933   Macromolecular complex subunit organization                                78      3.4452296820    5.78E-17
  GO:0006397   mRNA processing                                                            77      3.4010600707    7.10E-16
  GO:0065003   Macromolecular complex assembly                                            76      3.3568904594    1.18E-15
  GO:0051186   Cofactor metabolic process                                                 73      3.2243816254    1.27E-15
  GO:0007010   Cytoskeleton organization                                                  71      3.1360424028    5.24E-15
  GO:0022900   Electron transport chain                                                   67      2.9593639576    8.39E-15
  GO:0008380   RNA splicing                                                               67      2.9593639576    1.13E-14
  GO:0005996   Monosaccharide metabolic process                                           64      2.8268551237    1.89E-14
  GO:0006732   Coenzyme metabolic process                                                 60      2.6501766784    1.89E-14
  GO:0019318   Hexose metabolic process                                                   60      2.6501766784    1.97E-14
  GO:0006163   Purine nucleotide metabolic process                                        59      2.6060070671    1.97E-14
  GO:0034654   Nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process   59      2.6060070671    2.69E-14
  GO:0034404   Nucleobase, nucleoside and nucleotide biosynthetic process                 59      2.6060070671    3.59E-14
  GO:0034621   Cellular macromolecular complex subunit organization                       59      2.6060070671    5.07E-14
  GO:0009165   Nucleotide biosynthetic process                                            58      2.5618374558    5.92E-14
  GO:0016044   Membrane organization                                                      58      2.5618374558    9.05E-14
  GO:0048878   Chemical homeostasis                                                       58      2.5618374558    1.13E-13
  GO:0006631   Fatty acid metabolic process                                               57      2.5176678445    1.46E-13
  GO:0034622   Cellular macromolecular complex assembly                                   57      2.5176678445    1.48E-13
  GO:0009259   Ribonucleotide metabolic process                                           56      2.4734982332    1.53E-13
  GO:0009611   Response to wounding                                                       56      2.4734982332    1.89E-13
  GO:0009150   Purine ribonucleotide metabolic process                                    55      2.4293286219    4.22E-13
  GO:0032989   Cellular component morphogenesis                                           55      2.4293286219    4.40E-13
  GO:0006006   Glucose metabolic process                                                  54      2.3851590106    5.52E-13
  GO:0030030   Cell projection organization                                               54      2.3851590106    6.21E-13
  GO:0015980   Energy derivation by oxidation of organic compounds                        53      2.3409893993    7.03E-13
  GO:0006164   Purine nucleotide biosynthetic process                                     53      2.3409893993    1.41E-12
  GO:0007264   Small GTPase mediated signal transduction                                  53      2.3409893993    1.62E-12
  GO:0030029   Actin filament-based process                                               52      2.2968197880    1.65E-12
  GO:0009260   Ribonucleotide biosynthetic process                                        51      2.2526501767    2.84E-12
  GO:0006457   Protein folding                                                            51      2.2526501767    4.68E-12
  GO:0008610   Lipid biosynthetic process                                                 51      2.2526501767    5.69E-12
  GO:0050801   Ion homeostasis                                                            51      2.2526501767    5.93E-12
  GO:0009152   Purine ribonucleotide biosynthetic process                                 50      2.2084805654    6.56E-12
  GO:0030036   Actin cytoskeleton organization                                            50      2.2084805654    7.59E-12
  GO:0009141   Nucleoside triphosphate metabolic process                                  49      2.1643109541    8.27E-12
  GO:0009144   Purine nucleoside triphosphate metabolic process                           48      2.1201413428    8.27E-12
  GO:0009205   Purine ribonucleoside triphosphate metabolic process                       47      2.0759717314    9.26E-12
  GO:0009199   Ribonucleoside triphosphate metabolic process                              47      2.0759717314    1.50E-11
  GO:0006461   Protein complex assembly                                                   47      2.0759717314    1.50E-11
  GO:0070271   Protein complex biogenesis                                                 47      2.0759717314    1.50E-11
  GO:0006873   Cellular ion homeostasis                                                   47      2.0759717314    2.68E-11
  GO:0055082   Cellular chemical homeostasis                                              47      2.0759717314    4.71E-11
  GO:0032268   Regulation of cellular protein metabolic process                           46      2.0318021201    2.46E-10
  GO:0008283   Cell proliferation                                                         45      1.9876325088    2.89E-10
  GO:0009145   Purine nucleoside triphosphate biosynthetic process                        44      1.9434628975    4.24E-10
  GO:0009142   Nucleoside triphosphate biosynthetic process                               44      1.9434628975    9.73E-10
  GO:0009206   Purine ribonucleoside triphosphate biosynthetic process                    43      1.8992932862    1.48E-09
  GO:0009201   Ribonucleoside triphosphate biosynthetic process                           43      1.8992932862    1.48E-09
  GO:0045333   Cellular respiration                                                       42      1.8551236749    1.53E-09
  GO:0046034   ATP metabolic process                                                      42      1.8551236749    2.38E-09
  GO:0033043   Regulation of organelle organization                                       42      1.8551236749    2.96E-09
  GO:0006605   Protein targeting                                                          41      1.8109540636    5.08E-09
  GO:0032535   Regulation of cellular component size                                      41      1.8109540636    8.13E-09
  GO:0006119   Oxidative phosphorylation                                                  39      1.7226148410    9.12E-09
  GO:0043062   Extracellular structure organization                                       39      1.7226148410    1.14E-08
  GO:0016052   Carbohydrate catabolic process                                             38      1.6784452297    1.16E-08
  GO:0006754   ATP biosynthetic process                                                   38      1.6784452297    1.21E-08
  GO:0006575   Cellular amino acid derivative metabolic process                           38      1.6784452297    1.63E-08
  GO:0019226   Transmission of nerve impulse                                              38      1.6784452297    3.36E-08
  GO:0007017   Microtubule-based process                                                  37      1.6342756184    3.37E-08
  GO:0009719   Response to endogenous stimulus                                            36      1.5901060071    4.09E-08
  GO:0051493   Regulation of cytoskeleton organization                                    35      1.5459363958    6.21E-08
  GO:0046164   Alcohol catabolic process                                                  34      1.5017667845    8.50E-08
  GO:0016053   Organic acid biosynthetic process                                          34      1.5017667845    1.21E-07
  GO:0046394   Carboxylic acid biosynthetic process                                       34      1.5017667845    1.21E-07
  GO:0010324   Membrane invagination                                                      34      1.5017667845    1.42E-07
  GO:0006897   Endocytosis                                                                34      1.5017667845    1.81E-07
  GO:0009725   Response to hormone stimulus                                               33      1.4575971731    1.85E-07
  GO:0007517   Muscle organ development                                                   33      1.4575971731    3.23E-07
  GO:0055080   Cation homeostasis                                                         33      1.4575971731    4.24E-07
  GO:0044275   Cellular carbohydrate catabolic process                                    32      1.4134275618    7.66E-07
  GO:0008202   Steroid metabolic process                                                  32      1.4134275618    1.18E-06
  GO:0007268   Synaptic transmission                                                      32      1.4134275618    1.27E-06
  GO:0046395   Carboxylic acid catabolic process                                          30      1.3250883392    1.31E-06
  GO:0016054   Organic acid catabolic process                                             30      1.3250883392    1.31E-06
  GO:0044087   Regulation of cellular component biogenesis                                30      1.3250883392    1.49E-06
  GO:0006979   Response to oxidative stress                                               29      1.2809187279    1.49E-06
  GO:0033365   Protein localization in organelle                                          29      1.2809187279    1.50E-06
  GO:0030198   Extracellular matrix organization                                          29      1.2809187279    1.50E-06
  GO:0043623   Cellular protein complex assembly                                          29      1.2809187279    1.50E-06
  GO:0055066   Di-, trivalent inorganic cation homeostasis                                29      1.2809187279    1.65E-06
  GO:0015992   Proton transport                                                           28      1.2367491166    2.14E-06
  GO:0019320   Hexose catabolic process                                                   28      1.2367491166    2.24E-06
  GO:0006007   Glucose catabolic process                                                  28      1.2367491166    2.36E-06
  GO:0006818   Hydrogen transport                                                         28      1.2367491166    2.42E-06
  GO:0046365   Monosaccharide catabolic process                                           28      1.2367491166    3.04E-06
  GO:0032956   Regulation of actin cytoskeleton organization                              28      1.2367491166    3.40E-06
  GO:0032970   Regulation of actin filament-based process                                 28      1.2367491166    3.88E-06
  GO:0045454   Cell redox homeostasis                                                     28      1.2367491166    4.20E-06
  GO:0006913   Nucleocytoplasmic transport                                                28      1.2367491166    4.55E-06
  GO:0051169   Nuclear transport                                                          28      1.2367491166    6.02E-06
  GO:0051130   Positive regulation of cellular component organization                     28      1.2367491166    6.58E-06
  GO:0016042   Lipid catabolic process                                                    28      1.2367491166    7.04E-06
  GO:0010608   Post-transcriptional regulation of gene expression                         28      1.2367491166    8.39E-06
  GO:0030003   Cellular cation homeostasis                                                28      1.2367491166    9.47E-06
  GO:0015674   Di-, trivalent inorganic cation transport                                  28      1.2367491166    1.03E-05
  GO:0010035   Response to inorganic substance                                            27      1.1925795053    1.42E-05
  GO:0006790   Sulfur metabolic process                                                   27      1.1925795053    1.43E-05
  GO:0006333   Chromatin assembly or disassembly                                          27      1.1925795053    2.23E-05
  GO:0015986   ATP synthesis coupled proton transport                                     26      1.1484098940    2.39E-05
  GO:0015985   Energy coupled proton transport, down electrochemical gradient             26      1.1484098940    2.64E-05
  GO:0034220   Ion transmembrane transport                                                26      1.1484098940    2.89E-05
  GO:0008064   Regulation of actin polymerization or depolymerization                     26      1.1484098940    4.22E-05
  GO:0030832   Regulation of actin filament length                                        26      1.1484098940    4.27E-05
  GO:0043254   Regulation of protein complex assembly                                     26      1.1484098940    5.34E-05
  GO:0051129   Negative regulation of cellular component organization                     26      1.1484098940    5.34E-05
  GO:0042692   Muscle cell differentiation                                                26      1.1484098940    5.49E-05
  GO:0060537   Muscle tissue development                                                  26      1.1484098940    6.85E-05
  GO:0006511   Ubiquitin-dependent protein catabolic process                              26      1.1484098940    7.99E-05
  GO:0006518   Peptide metabolic process                                                  25      1.1042402827    8.11E-05
  GO:0032271   Regulation of protein polymerization                                       25      1.1042402827    8.43E-05
  GO:0014706   Striated muscle tissue development                                         25      1.1042402827    1.02E-04
  GO:0051050   Positive regulation of transport                                           25      1.1042402827    1.25E-04
  GO:0030005   Cellular di-, tri-valent inorganic cation homeostasis                      25      1.1042402827    1.79E-04
  GO:0006323   DNA packaging                                                              24      1.0600706714    1.90E-04
  GO:0042060   Wound healing                                                              24      1.0600706714    1.91E-04
  GO:0006084   Acetyl-CoA metabolic process                                               23      1.0159010601    2.00E-04
  GO:0006096   Glycolysis                                                                 23      1.0159010601    2.24E-04
  GO:0030833   Regulation of actin filament polymerization                                23      1.0159010601    2.66E-04
  GO:0006399   tRNA metabolic process                                                     23      1.0159010601    2.72E-04
  GO:0051187   Cofactor catabolic process                                                 22      0.9717314487    2.96E-04
  GO:0043244   Regulation of protein complex disassembly                                  22      0.9717314487    3.73E-04
  GO:0031589   Cell-substrate adhesion                                                    22      0.9717314487    4.24E-04
  GO:0051146   Striated muscle cell differentiation                                       22      0.9717314487    4.24E-04
  GO:0051188   Cofactor biosynthetic process                                              22      0.9717314487    4.87E-04
  GO:0007018   Microtubule-based movement                                                 22      0.9717314487    4.87E-04
  GO:0022904   Respiratory electron transport chain                                       21      0.9275618374    4.87E-04
  GO:0009109   Coenzyme catabolic process                                                 21      0.9275618374    5.98E-04
  GO:0015931   Nucleobase, nucleoside, nucleotide and nucleic acid transport              21      0.9275618374    6.05E-04
  GO:0031497   Chromatin assembly                                                         21      0.9275618374    6.14E-04
  GO:0065004   Protein-DNA complex assembly                                               21      0.9275618374    6.22E-04
  GO:0017038   Protein import                                                             21      0.9275618374    6.40E-04
  GO:0050878   Regulation of body fluid levels                                            21      0.9275618374    6.65E-04
  GO:0005976   Polysaccharide metabolic process                                           21      0.9275618374    6.65E-04
  GO:0009060   Aerobic respiration                                                        20      0.8833922261    6.65E-04
  GO:0006418   tRNA aminoacylation for protein translation                                20      0.8833922261    8.53E-04
  GO:0043039   tRNA aminoacylation                                                        20      0.8833922261    8.84E-04
  GO:0043038   Amino acid activation                                                      20      0.8833922261    9.32E-04
  GO:0007160   Cell-matrix adhesion                                                       20      0.8833922261    9.32E-04
  GO:0007015   Actin filament organization                                                20      0.8833922261    1.02E-03
  GO:0010639   Negative regulation of organelle organization                              20      0.8833922261    1.13E-03
  GO:0050657   Nucleic acid transport                                                     20      0.8833922261    1.13E-03
  GO:0051236   Establishment of RNA localization                                          20      0.8833922261    1.22E-03
  GO:0050658   RNA transport                                                              20      0.8833922261    1.23E-03
  GO:0006403   RNA localization                                                           20      0.8833922261    1.32E-03
  GO:0006334   Nucleosome assembly                                                        20      0.8833922261    1.42E-03
  GO:0034728   Nucleosome organization                                                    20      0.8833922261    1.45E-03
  GO:0006099   Tricarboxylic acid cycle                                                   19      0.8392226148    1.46E-03
  GO:0046356   Acetyl-CoA catabolic process                                               19      0.8392226148    1.47E-03
  GO:0009064   Glutamine family amino acid metabolic process                              19      0.8392226148    1.47E-03
  GO:0051494   Negative regulation of cytoskeleton organization                           19      0.8392226148    1.71E-03
  GO:0019748   Secondary metabolic process                                                19      0.8392226148    1.84E-03
  GO:0030031   Cell projection assembly                                                   19      0.8392226148    2.06E-03
  GO:0007599   Hemostasis                                                                 19      0.8392226148    2.06E-03
  GO:0016125   Sterol metabolic process                                                   19      0.8392226148    2.06E-03
  GO:0006417   Regulation of translation                                                  19      0.8392226148    2.06E-03
  GO:0043242   Negative regulation of protein complex disassembly                         18      0.7950530035    2.06E-03
  GO:0006800   Oxygen and reactive oxygen species metabolic process                       18      0.7950530035    2.16E-03
  GO:0048193   Golgi vesicle transport                                                    18      0.7950530035    2.26E-03
  GO:0051028   mRNA transport                                                             18      0.7950530035    2.33E-03
  GO:0008203   Cholesterol metabolic process                                              18      0.7950530035    2.34E-03
  GO:0007596   Blood coagulation                                                          18      0.7950530035    2.44E-03
  GO:0050817   Coagulation                                                                18      0.7950530035    2.73E-03
  GO:0002526   Acute inflammatory response                                                18      0.7950530035    2.78E-03
  GO:0042493   Response to drug                                                           18      0.7950530035    2.84E-03
  GO:0006749   Glutathione metabolic process                                              17      0.7508833922    2.86E-03
  GO:0030834   Regulation of actin filament depolymerization                              17      0.7508833922    2.86E-03
  GO:0044242   Cellular lipid catabolic process                                           17      0.7508833922    3.04E-03
  GO:0051170   Nuclear import                                                             17      0.7508833922    3.19E-03
  GO:0055001   Muscle cell development                                                    17      0.7508833922    3.26E-03
  GO:0009310   Amine catabolic process                                                    17      0.7508833922    3.28E-03
  GO:0009309   Amine biosynthetic process                                                 17      0.7508833922    3.34E-03
  GO:0051248   Negative regulation of protein metabolic process                           17      0.7508833922    3.34E-03
  GO:0006633   Fatty acid biosynthetic process                                            17      0.7508833922    3.34E-03
  GO:0060627   Regulation of vesicle-mediated transport                                   17      0.7508833922    3.77E-03
  GO:0009791   Post-embryonic development                                                 17      0.7508833922    3.99E-03
  GO:0018130   Heterocycle biosynthetic process                                           16      0.7067137809    4.28E-03
  GO:0055002   Striated muscle cell development                                           16      0.7067137809    4.35E-03
  GO:0034504   Protein localization in nucleus                                            16      0.7067137809    4.53E-03
  GO:0032269   Negative regulation of cellular protein metabolic process                  16      0.7067137809    5.12E-03
  GO:0002449   Lymphocyte mediated immunity                                               16      0.7067137809    5.13E-03
  GO:0030835   Negative regulation of actin filament depolymerization                     15      0.6625441696    5.13E-03
  GO:0032272   Negative regulation of protein polymerization                              15      0.6625441696    5.25E-03
  GO:0031333   Negative regulation of protein complex assembly                            15      0.6625441696    5.46E-03
  GO:0000302   Response to reactive oxygen species                                        15      0.6625441696    5.56E-03
  GO:0051258   Protein polymerization                                                     15      0.6625441696    5.56E-03
  GO:0009063   Cellular amino acid catabolic process                                      15      0.6625441696    5.56E-03
  GO:0006606   Protein import into nucleus                                                15      0.6625441696    6.69E-03
  GO:0070482   Response to oxygen levels                                                  15      0.6625441696    6.69E-03
  GO:0006694   Steroid biosynthetic process                                               15      0.6625441696    6.69E-03
  GO:0042773   ATP synthesis coupled electron transport                                   14      0.6183745583    6.74E-03
  GO:0051693   Actin filament capping                                                     14      0.6183745583    7.11E-03
  GO:0042743   Hydrogen peroxide metabolic process                                        14      0.6183745583    7.27E-039
  GO:0034599   Cellular response to oxidative stress                                      14      0.6183745583    7.31E-03
  GO:0042542   Response to hydrogen peroxide                                              14      0.6183745583    8.12E-03
  GO:0030837   Negative regulation of actin filament polymerization                       14      0.6183745583    8.13E-03
  GO:0034330   Cell junction organization                                                 14      0.6183745583    8.55E-03
  GO:0006413   Translational initiation                                                   14      0.6183745583    8.62E-03
  GO:0008652   Cellular amino acid biosynthetic process                                   14      0.6183745583    8.74E-03
  GO:0006997   Nucleus organization                                                       14      0.6183745583    9.32E-03

Q, value calculated from p-value by Benjamini-Hochberg-Yekutieli multiple testing correction with Fisher discriminant analysis.

###### 

Pathway analysis in the round spermatid proteome using the Kyoto Encyclopedia of Genes and Genomes (KEGG) and the BioCarta Pathway databases.

  Source     Term                                                                           Count   \%    P         Q[a](#tfn2-mmr-10-04-2009){ref-type="table-fn"}
  ---------- ------------------------------------------------------------------------------ ------- ----- --------- -------------------------------------------------
  KEGG       Ribosome                                                                       68      3.0   6.5E-32   1.2E-29
  KEGG       Oxidative phosphorylation                                                      81      3.6   3.2E-28   2.9E-26
  KEGG       Parkinson's disease                                                            73      3.2   6.9E-21   4.2E-19
  KEGG       Alzheimer's disease                                                            85      3.8   2.1E-18   9.6E-17
  KEGG       Valine, leucine and isoleucine degradation                                     36      1.6   1.9E-17   7.0E-16
  KEGG       Huntington's disease                                                           83      3.7   4.8E-17   1.5E-15
  KEGG       Fatty acid metabolism                                                          34      1.5   1.1E-15   2.9E-14
  KEGG       Citrate (TCA) cycle                                                            27      1.2   4.2E-15   9.8E-14
  KEGG       Spliceosome                                                                    60      2.7   6.8E-14   1.4E-12
  KEGG       Glycolysis/Gluconeogenesis                                                     38      1.7   2.3E-11   4.3E-10
  KEGG       Propanoate metabolism                                                          23      1.0   7.5E-11   1.3E-9
  KEGG       Glutathione metabolism                                                         30      1.3   1.6E-9    2.5E-8
  KEGG       Proteasome                                                                     28      1.2   2.4E-9    3.5E-8
  KEGG       Pyruvate metabolism                                                            25      1.1   1.1E-8    1.5E-7
  KEGG       Focal adhesion                                                                 66      2.9   5.7E-7    7.0E-6
  KEGG       Butanoate metabolism                                                           21      0.9   1.1E-6    1.3E-5
  KEGG       ECM-receptor interaction                                                       35      1.5   1.3E-6    1.4E-5
  KEGG       Drug metabolism                                                                31      1.4   9.6E-6    9.9E-5
  KEGG       PPAR signaling pathway                                                         32      1.4   1.1E-5    1.1E-4
  KEGG       Arginine/proline metabolism                                                    24      1.1   2.2E-5    2.1E-4
  KEGG       Tight junction                                                                 44      1.9   1.0E-4    9.2E-4
  KEGG       Lysosome                                                                       40      1.8   1.1E-4    9.2E-4
  KEGG       Metabolism of xenobiotics by cytochrome P450                                   26      1.1   1.5E-4    1.2E-3
  KEGG       β-alanine metabolism                                                           13      0.6   1.5E-4    1.2E-3
  KEGG       Tryptophan metabolism                                                          18      0.8   3.5E-4    2.6E-3
  KEGG       Alanine, aspartate and glutamate metabolism                                    15      0.7   3.7E-4    2.6E-3
  KEGG       Protein export                                                                 7       0.3   7.7E-4    5.3E-3
  KEGG       Fatty acid elongation in mitochondria                                          7       0.3   7.7E-4    5.3E-3
  KEGG       Starch and sucrose metabolism                                                  16      0.7   1.0E-3    6.6E-3
  KEGG       Pentose phosphate pathway                                                      13      0.6   1.1E-3    6.9E-3
  KEGG       Leukocyte transendothelial migration                                           37      1.6   1.1E-3    6.8E-3
  KEGG       Cardiac muscle contraction                                                     27      1.2   1.1E-3    6.7E-3
  KEGG       Valine, leucine and isoleucine biosynthesis                                    8       0.4   1.2E-3    6.8E-3
  KEGG       Porphyrin and chlorophyll metabolism                                           14      0.6   1.4E-3    7.9E-3
  KEGG       Adherens junction                                                              26      1.1   1.7E-3    9.3E-3
  KEGG       Aminoacyl-tRNA biosynthesis                                                    17      0.8   2.1E-3    1.1E-2
  KEGG       Galactose metabolism                                                           12      0.5   5.8E-3    2.9E-2
  KEGG       Regulation of actin cytoskeleton                                               56      2.5   6.2E-3    3.0E-2
  KEGG       Pentose and glucuronate interconversions                                       9       0.4   6.5E-3    3.1E-2
  KEGG       Arrhythmogenic right ventricular cardiomyopathy                                24      1.1   6.9E-3    3.2E-2
  KEGG       Amino sugar and nucleotide sugar metabolism                                    16      0.7   9.6E-3    4.4E-2
  KEGG       Limonene and pinene degradation                                                8       0.4   1.2E-2    5.1E-2
  KEGG       Ascorbate and aldarate metabolism                                              8       0.4   1.2E-2    5.1E-2
  KEGG       Phenylalanine metabolism                                                       10      0.4   1.2E-2    5.1E-2
  KEGG       Long-term potentiation                                                         22      1.0   1.2E-2    5.2E-2
  KEGG       Fc γ R-mediated phagocytosis                                                   28      1.2   1.7E-2    6.8E-2
  KEGG       Glyoxylate and dicarboxylate metabolism                                        8       0.4   1.7E-2    6.9E-2
  KEGG       Tyrosine metabolism                                                            14      0.6   1.9E-2    7.3E-2
  KEGG       Gap junction                                                                   25      1.1   2.0E-2    7.5E-2
  KEGG       Synthesis and degradation of ketone bodies                                     6       0.3   2.3E-2    8.7E-2
  KEGG       Lysine degradation                                                             14      0.6   2.8E-2    1.0E-1
  KEGG       N-glycan biosynthesis                                                          15      0.7   3.3E-2    1.2E-1
  KEGG       Prion diseases                                                                 12      0.5   4.5E-2    1.5E-1
  KEGG       Long-term depression                                                           20      0.9   6.0E-2    2.0E-1
  KEGG       Fructose and mannose metabolism                                                12      0.5   6.5E-2    2.1E-1
  KEGG       Oocyte meiosis                                                                 29      1.3   6.7E-2    2.1E-1
  KEGG       Renin-angiotensin system                                                       7       0.3   9.7E-2    2.9E-1
  BioCarta   Shuttle for transfer of acetyl groups from mitochondria to the cytosol         8       0.4   7.9E-5    1.7E-2
  BioCarta   uCalpain and friends in cell spread                                            8       0.4   3.7E-3    3.3E-1
  BioCarta   ERAD pathway                                                                   9       0.4   6.6E-3    3.8E-1
  BioCarta   AKAP95 role in mitosis and chromosome dynamics                                 6       0.3   1.9E-2    6.4E-1
  BioCarta   Agrin in postsynaptic differentiation                                          11      0.5   2.2E-2    6.1E-1
  BioCarta   Cycling of Ran in nucleocytoplasmic transport                                  4       0.2   2.7E-2    6.2E-1
  BioCarta   Protein kinase A at the centrosome                                             7       0.3   2.9E-2    6.0E-1
  BioCarta   Caspase cascade in apoptosis                                                   9       0.4   4.1E-2    6.8E-1
  BioCarta   Endocytotic role of NDK, phosphins and dynamin                                 5       0.2   5.5E-2    7.4E-1
  BioCarta   Role of β-arrestins in the activation and targeting of MAP kinases             7       0.3   6.0E-2    7.3E-1
  BioCarta   How progesterone initiates the oocyte maturation                               8       0.4   8.5E-2    8.2E-1
  BioCarta   Role of Ran in mitotic spindle regulation                                      5       0.2   8.5E-2    7.9E-1
  BioCarta   ChREBP regulation by carbohydrates and cAMP                                    5       0.2   8.5E-2    7.9E-1
  BioCarta   CFTR and b2AR pathway                                                          5       0.2   8.5E-2    7.9E-1
  BioCarta   Rho-selective guanine exchange factor AKAP13 mediates stress fiber formation   4       0.2   9.8E-2    8.2E-1

Q, value calculated from p-value by Benjamini-Hochberg-Yekutieli multiple testing correction.

ECM, extracellular matrix; PPAR, peroxisome proliferator-activated receptors; ERAD, endoplasmic-reticulum-associated degradation; AKAP, A-kinase anchoring protein; NDK, nucleoside diphosphate kinase; ChREBP, carbohydrate-responsive element-binding protein; CFTR, cystic fibrosis transmembrane conductance regulator; b2AR, β 2 adrenergic receptor
